Key Takeaways Acadia's Q3 adjusted EPS of 72 cents beat estimates but dropped 20.9% year over year.Revenues grew 4.4% to $851.6M, driven by higher admissions and patient days despite cost pressure.Guidance was cut, with 2025 EPS now seen at $2.35-$2.45 and revenue at $3.28-$3.30B.Acadia Healthcare Company, Inc. (ACHC) reported adjusted third-quarter earnings of 72 cents per share, which beat the Zacks Consensus Estimate by 7.5%. However, the bottom line declined 20.9% year over year. Total revenues increase ...

If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?Edmund Ingham is a biotech consultant. He has been covering biotech, healthcare, and pharma for over 5 years, and has put together detailed reports of over 1,000 companies. He leads the investing group Haggerston B ...

If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?Edmund Ingham is a biotech consultant. He has been covering biotech, healthcare, and pharma for over 5 years, and has put together detailed reports of over 1,000 companies. He leads the investing group Haggerston B ...

Acadia Healthcare Company (NasdaqGS:ACHC) Q3 2025 Earnings Call November 06, 2025 09:00 AM ET Speaker1Thank you for standing by. My name is Lacey, and I will be your conference operator today. At this time, I would like to welcome everyone to the Acadia Healthcare Third Quarter 2025 earnings call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during this time, simply press Star ...

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:Acadia Healthcare Company, Inc. (ACHC) is a provider of behavioral healthcare services. The Zacks Consensus Estimate for its current year earnings has been revised 3.2% downward over the last 60 days.Forward Air Corporation (FWRD) is a freight and logistics company. The Zacks Consensus Estimate for its current year earnings has been revised 12% downward over the last 60 days.Century Aluminum Company (CENX) is an aluminum products comp ...

Acadia Healthcare (ACHC) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.67 per share. This compares to earnings of $0.91 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +7.46%. A quarter ago, it was expected that this provider of inpatient behavioral health care services would post earnings of $0.71 per share when it actually produced earnings of $0.83, delivering a surprise of ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission File Number: 001-35331 Acadia Healthcare Company, Inc. (Exact name of registrant as specified in its charter) Dela ...

Exhibit 99 ACADIA HEALTHCARE REPORTS THIRD QUARTER 2025 RESULTS Third Quarter Revenue of $851.6 Million Increased 4.4% Year-Over-Year Lowering Full-Year Outlook Acadia Taking Decisive Actions to Optimize Portfolio in Order to Reduce Capital Expenditures and Increase Free Cash Flow Generation Referral Initiatives Drive Accelerating Admissions Growth Todd Young joined as CFO on October 27; Announces departure of COO Dr. Nasser Khan FRANKLIN, Tenn. (November 5, 2025) – Acadia Healthcare Company, Inc. ("Acadia" ...

Core Insights - The health care sector is experiencing a trend of oversold stocks, presenting potential buying opportunities for undervalued companies [1][2] Company Summaries - **Alvotech SA (NASDAQ:ALVO)**: Received an FDA Complete Response Letter for its AVT05 biosimilar application, leading to a revised outlook for 2025. The stock has fallen approximately 41% over the past month, with a 52-week low of $4.81. Current RSI is 18.8, and shares closed at $5.03 after a 34.3% drop [7] - **Acadia Healthcare Company Inc (NASDAQ:ACHC)**: Set to release third quarter 2025 results on November 5. The stock has decreased around 19% in the past month, with a 52-week low of $17.12. Current RSI is 27.9, and shares closed at $21.31 after a 0.9% decline [8] - **Akebia Therapeutics Inc (NASDAQ:AKBA)**: Reported inducement grants under Nasdaq Listing Rule 5635(c)(4). The stock has fallen about 33% over the past five days, with a 52-week low of $1.52. Current RSI is 29.4, and shares closed at $2.12 after a 4.1% drop [8]

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.Here's the latest list of major oversold players ...